loss-of-function rna interference screen molecular targets cancer 
pursuit novel therapeutic agents cancer relies identification validation molecular targets hallmarks cancer include self-sufficiency growth signals evasion apoptosis genes regulate processes may optimal therapeutic attack describe loss-of-function screen genes required proliferation survival cancer cells using rna interference library used doxycycline-inducible retroviral vector expression small hairpin rnas shrnas construct library targeting human genes used retroviral pools library infect cell lines representing two distinct molecular subgroups diffuse large b-cell lymphoma dlbcl termed activated b-cell-like dlbcl germinal centre b-cell-like dlbcl vector engineered contain unique base-pair bar code allowing abundance individual shrna vector within population transduced cells measured using microarrays bar-code sequences observed subset shrna vectors depleted transduced cells three weeks culture shrna expression induced activated b-cell-like dlbcl cells germinal centre b-cell-like dlbcl cells shrnas targeting nf-kappa b pathway depleted keeping essential role pathway survival activated b-cell-like dlbcl screen uncovered card11 key upstream signalling component responsible constitutive kappa b kinase activity activated b-cell-like dlbcl methodology describe can used establish functional taxonomy cancer help reveal new classes therapeutic targets distinct known oncogenes 
